α-Synuclein functions as a negative regulator for expression of tyrosine hydroxylase

Acta Neurologica Belgica

Volumn 111, Issue 2, 2011, Pages 130-135

  Li, Yao Hua ^a   Gao, Nan ^a   Ye, Yi Wen ^a   Li, Xin ^a   Yu, Shun ^a   Yang, Hui ^b   Uéda, Kenji ^a,c   Chan, Piu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Dopaminergic neurons; Luciferase; Promoter; Tyrosine hydroxylase; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; GENOMIC DNA; LUCIFERASE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE;

EID: 79959429128     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., et al. Mice lacking alpha-synu- clein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25:239-252.
2. Arima K., Ueda K., Sunohara N., Hirai S., Izumiyama Y., et al. Immunoelectron-microscopic demonstration of NaCP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies inParkinson's disease and in dementia with Lewy bodies. Brain Res. 1998;808:93-100.
3. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K., et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol. 1998;152: 879-884.
4. Chartier-Harlin MC, Kachergus J, Roumier C., Mouroux V., Douay X., et al. Alpha-Synuclein locus duplication as a cause of familial Parkinson's disease. Lancet. 2004;364: 1167-1169.
5. Chu Y, Kordower J.H. Age-associated increases of α-synuclein in monkeys and humans are associated with nigralstriatal dopamine depletion: is this the target for Parkinson's disease? Neurobiol dis. 2007;25:134-149.
6. George JM. The synucleins. Genome Biol.2002;3:3002.
7. ibáñez P., Bonnet A.M., Débarges B., Lohmann E., Tison F., et al. Causal relation between alpha- synuclein gene duplication and familial Parkinson's disease. Lancet. 2004;364:1169-1171.
8. Kim T, Park M, Choi E., Lee H., Lee S., et al. Cloningand cell type-specific regulation of the human tyrosine hydroxylase gene promoter. Biochem Biophys Res Commun. 2003;312:1123-31.
9. Krüger R, Kuhn W, Müller T, Woitalla D., Graeber M., et al. Ala30Pro mutation in the gene encoding alpha- synuclein in Parkinson's disease. Nat Genet. 1998;18:106-8.
10. Lotharius J, Brundin P. Pathogenesis of Parkinson's disease:dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci. 2002;3:932-942.
11. Ma Q.L., Chan P., Yoshii M., Ueda K. Alpha-synuclein aggregation and neurodegenerative diseases. J alzheimers dis. 2003;5:139-48.
12. Nagatsu T., Levitt M., Uderfriend S. Tyrosine hydroxy-lase, the initial step in norepinephrine biosynthesis. J Biol Chem. 1964;239:2910-2917.
13. Perez RG, Waymire JC, Lin E., Liu J.J., Guo F., et al. A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 2002;22: 3090-3099.
14. Perez R.G, Hastings T.G. Could a loss of alpha-synuclein function put dopaminergic neurons at risk? J Neurochem. 2004;89:1318-1324.
15. Polymeropoulos M.H, Lavedan C., Leroy E., Ide S., Dehejia A., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047.
16. Rochet JC, outeiro TF, Conway K., ding TT., Volles MJ., et al. Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for under- standing neurodegeneration in Parkinson's disease. J Mol Neurosci. 2004;23:23-34.
17. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., et al. Alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003;302:841.
18. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R., et al. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839-840.
19. Tehranian R, Montoya S.E., van Laar A.D., Hastings T.G., Perez R.G. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells. J Neurochem. 2006;99:1188-1196.
20. Xu S, Zhou M, Yu S, Cai Y, Zhang A., et al. Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells. Biochem Biophys Res Commun. 2006;342:330-335.
21. Yu S, Li X, Liu G, Han J, Zhang C., et al. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal anti- body. Neuroscience. 2007;145:539-55.
22. Yu S, Zuo X, Li Y, Zhang C, Zhou M., et al. inhibition of tyrosine hydroxylase expression in， alpha- synuclein-transfected dopaminergic neuronal cells. Neurosci Lett. 2004;367:34-39.
23. Zarranz JJ, alegre J, Gómez-esteban JC, Lezcano E., Ros R., et al. The new mutation, e46K, of alpha- synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55:153-156.
24. Zigmond R.E., Schwarzschild M.A., Rittenhouse A.R. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphoryla-tion. Annu Rve Neurosci. 1989;12:415-461.